Our Plan
We are accelerating breakthroughs to find a solve for FSHD by December 31, 2027.
Our Approach
Driving Innovation to Advance FSHD Research and Therapies
SOLVE FSHD is focused on supporting:
- The development, validation and clinical evaluation of biomarkers that predict clinically meaningful outcome measures for use in clinical trials in FSHD.
- Biomarker discovery and Natural History Studies that support drug development efforts.
- Development of pre-clinical systems to increase data quality and success for future therapies advancing to the clinic.
- Development of novel therapies that stop disease progression and/or increase muscle regeneration.
Our Approach to Funding
Facilitate developing therapeutics that maintain or improve muscle function, demonstrated by an improvement
in muscle strength.
Invest in companies to catalyze a cure through disease modifying treatments.
Funded to Date
$
0
Funds Committed: $100 million